Suggested remit: To appraise the clinical and cost effectiveness of AR101 within its marketing authorisation for treating peanut allergy.
 
Status In progress
Process STA 2018
ID number 1282

Project Team

Project lead Michelle Adhemar

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
08 January 2021 The Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of AR101 within its marketing authorisation for treating peanut allergy. I also felt it helpful to write and advise you of the draft timelines we have planned for your information. The appraisal is expected to start in approximately early March 2021 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately late May 2021.
08 January 2021 In progress. Topic is in progress
06 August 2020 - 04 September 2020 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance